| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $650.9M | +12.9% |
| Cost of Revenue | $541.8M | +14.6% |
| Gross Profit | $109.2M | +5.2% |
| R&D Expense | $27.6M | -5.2% |
| SG&A Expense | $27.7M | +8.7% |
| Operating Income | $40.3M | +2.6% |
| Pre-tax Income | $44.1M | -8.5% |
| Income Tax | $5.9M | +14.7% |
| Net Income | $30.0M | -20.4% |
| EPS (Basic) | $0.99 | -20.8% |
| EPS (Diluted) | $0.99 | -20.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.0M | -50.3% |
| Short-term Investments | $27.6M | +148.7% |
| Inventory | $112.6M | +0.1% |
| Current Assets | $602.6M | +6.8% |
| Total Assets | $850.6M | +11.0% |
| Current Liabilities | $456.5M | +19.0% |
| Long-term Debt | $842K | -31.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.8M | -50.9% |
| Capital Expenditures | $43.7M | +139.4% |
| Investing Cash Flow | -$77.9M | -172.1% |
| Financing Cash Flow | $17.4M | +155.4% |
| Free Cash Flow | -$33.9M | -2127.5% |
| Total Liabilities |
| $460.8M |
| +15.8% |
| Stockholders' Equity | $349.6M | +1.5% |